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Introduction
T-lymphocytes contribute to osteolysis in rheumatic dis-
eases through their production of the osteoclastogenic
cytokine RANKL. Mitogenic stimulation of lymphocytes
has been shown to induce expression of RANKL; how-
ever, the extracellular events leading to its production
have not been identified.
Aim
We sought to determine whether cell-to-cell interactions
through adhesion molecules such as lymphocyte func-
tion-associated antigen 2 (CD2) were necessary to pro-
mote RANKL secretion from T-cells.
Patients and methods
Human CD4+ and CD8+ T cells were purified by negative
selection. PBMC from rheumatoid arthritis (RA) patients
were obtained from Conversant Healthcare Systems. Cells
were cultured in medium supplemented with human
serum, IL-2, IL-7, M-CSF and 1alpha,25-dihydroxyvitamin
D3 in the presence of various combinations of bead bound
anti-CD3, anti-CD2 and anti-CD28 antibodies for 4 days.
Total RANKL was determined by osteoprotegrin capture
sandwich ELISA and secreted cytokines by Meso Scale
Discovery assay. T-cell activation was determined by flow
cytometry using CD69 and CD25.
Results
RANKL secretion by healthy donor PBMC was first
detected after 72 hr incubation with anti-CD3/CD2/
CD28 antibodies. Anti-CD3/CD28 antibodies failed
to induce detectable levels of RANKL. Both CD4+ and
CD8+ T-cells produced RANKL only in response to the
combined cross-linking of CD3 and CD2 whereas cross-
linking of CD3 and CD28 was insufficient to promote
RANKL expression even though the T-cells were acti-
vated. Those conditions (anti-CD3/CD2) that led to
increased RANKL secretion induced significantly lower
levels of TNF-a and IL-4 as compared to the combina-
tions of anti-CD3/CD28 or anti-CD3/CD2/CD28 antibo-
dies. Anti-CD2/CD28 antibodies did not induce RANKL
secretion. PBMC from RA patients also secreted RANKL
in a CD3/CD2-dependent manner and at levels similar
to PBMC from healthy donors.
Conclusions
Our results demonstrate that T-lymphocytes can gener-
ate RANKL following the co-ligation of the TCR/CD3
and the adhesion molecule CD2 in the absence of the
co-stimulatory receptor CD28, suggesting that interac-
tions between T-cells and non-traditional APCs (e.g.,
synovial fibroblasts) could lead to the production of
osteoclastogenic cytokines without the need for other
co-stimulatory signals.
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